SCHEMBL15085518

SCHEMBL15085518

Cn1c(=O)c2c(n(C)c1=O)n(C)c(=[Pt])n2C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 3/20 0.39
LMNA P02545 1/20 0.39
ADORA2A P29274 2/20 0.37
PIK3CD O00329 1/20 0.37
POLB P06746 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
CNR1 P21554 1/20 0.37
ACHE P22303 1/20 0.37
ADORA1 P30542 1/20 0.37
NTSR1 P30989 1/20 0.37
MC3R P41968 1/20 0.37
NOTUM Q6P988 1/20 0.37
SIRT3 Q9NTG7 1/20 0.37
GDA Q9Y2T3 1/20 0.37
NR2E1 Q9Y466 1/20 0.37
LGMN Q99538 1/20 0.37
KMT2A Q03164 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
CYP2C19 P33261 2/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2199114 0.82 ADORA2A (0.33) ADORA2BLMNAADORA2AKMT2AALDH1A1
SCHEMBL2197919 0.81 ADORA2A (0.35) ADORA2BADORA2AADORA1KMT2AALDH1A1
SCHEMBL2195281 0.80 ADORA2A (0.37) ADORA2BADORA2AADORA1KMT2ATSHR
SCHEMBL2195094 0.79 ADORA2A (0.38) ADORA2BADORA2AADORA3TSHRALDH1A1
SCHEMBL2193199 0.79 ADORA2A (0.38) ADORA2BADORA2AADORA3TSHRALDH1A1
SCHEMBL2196088 0.79 ADORA2A (0.38) ADORA2BADORA2AADORA3TSHRALDH1A1
SCHEMBL2193792 0.79 ADORA2A (0.38) ADORA2BADORA2AADORA3TSHRALDH1A1
SCHEMBL2194634 0.77 TSHR (0.41) ADORA2BLMNAKMT2ARXFP1TSHR
SCHEMBL2192321 0.77
SCHEMBL2196818 0.76 ALDH1A1 (0.40) ADORA2BLMNAADORA2AKMT2ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8481522-B2 Platinum-N-heterocyclic carbene derivatives, preparation thereof and therapeutic use thereof SANOFI (FR) 2013-07-09 US disclosed